Naloxone-insensitive transport effects of loperamide in guinea-pig gallbladder epithelium.
The effects of the antidiarrheal drug, loperamide, on HCO3 and Na transport across guinea-pig gallbladder epithelium were investigated using Ussing-chamber methods. Under basal conditions, mucosal loperamide (10(-4) mol/l) moderately lowered both the absorptive (JHCO3ms) and the secretory HCO3 flux (JHCO3sm) (pH-stat method), most likely by changing paracellular HCO3 flow. Exposure to serosal prostaglandin E1 (10(-6) mol/l) abolished Na absorption and turned HCO3 secretion electrogenic. The associated short-circuit current (Isc) was inhibited by loperamide in a concentration-dependent manner; mucosal addition (threshold at 3 x 10(-6) mol/l) of the drug was more effective. Inhibition of Isc was related to a decrease in JHCO3sm, but exceeded the drop in JHCO3net. The effects on JHCO3sm and Isc were mimicked by [Met5]enkephalin. Naloxone (10(-6) mol/l) was unable to influence the effects of loperamide and [Met5]enkephalin on Isc. There were no pro-absorptive effects of loperamide on unidirectional Na fluxes. We conclude that antisecretory properties of loperamide are solely due to inhibition of electrogenic HCO3 secretion, an effect unrelated to opiate receptor binding.
Wehner
F
F
Institut für Pharmakologie, Medizinischen Fakultät, Rheinisch-Westfälische Technische Hochschule Aachen, F.R.G.
Winterhager
J M
JM
Petersen
K U
KU
D000527:Alprostadil / Q000494:pharmacology; D000818:Animals; D001639:Bicarbonates / Q000378:metabolism; D001692:Biological Transport / Q000187:drug effects; D004594:Electrophysiology; D004744:Enkephalin, Methionine / Q000378:metabolism; D004848:Epithelium / Q000187:drug effects / Q000378:metabolism; D005704:Gallbladder / Q000187:drug effects / Q000378:metabolism; D006168:Guinea Pigs; D066298:In Vitro Techniques; D007408:Intestinal Absorption / Q000187:drug effects; D008139:Loperamide / Q000494:pharmacology*; D008297:Male; D009270:Naloxone / Q000494:pharmacology*; D010880:Piperidines / Q000494:pharmacology*; D011957:Receptors, Opioid / Q000187:drug effects; D012964:Sodium / Q000378:metabolism; D012979:Sodium Radioisotopes
D001639:Bicarbonates; D010880:Piperidines; D011957:Receptors, Opioid; D012979:Sodium Radioisotopes; D009270:Naloxone; D004744:Enkephalin, Methionine; D008139:Loperamide; D012964:Sodium; D000527:Alprostadil